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(a-e) Small RNA was extracted from HeLa cells transfected with ASO-miR-346 or ASO-miR-138 and control oligomers; pri-miR-346, pri-miR-346 loop mut (Note: used different forward primers in Table S1 , 346 Frd and 346 mut Frd to amplify miR-346, miR-346 loop mut, respectively) or pri-miR-138 and pcDNA3 as the control vector, and the expression of miR-346 and miR-138 was measured by qRT-PCR. U6 snRNA was regarded as the endogenous normalizer and the relative miR-346 and miR-138 expression levels (mean ± SD) were shown (* p < 0.05). Tables S1-S2 Table S1 . Primer sequences and oligomers used in this study 
Supplementary methods

Oligonucleotides and plasmids
The primers used to construct the pri-miRNA, hTERT, ACVR2B and SMAD3 mRNA 3'UTRs, hTERT and GRSF1 overexpression vectors and shR-hTERT and shR-GRSF1 plasmids were obtained from the Beijing AuGCT Inc, China. 2-O'-methyl-and 3'-amino-C6-modified anti-miRNA oligomers, miR-138/miR-346-loop mimics, miR-138/miR-346-loop mut mimics, siRNA-AGO2 and biotin-conjugated or unconjugated miR-346, miR-346 loop mut and hTERT mRNA fragments (38 nts) were purchased from Genepharma (Shanghai, China). Details of the primer sequences and oligomers can be found in Table S1 . 
Cell viability, colony formation and growth curve assays
EGFP reporter assay
The EGFP reporter assay was performed as previously described 1 . In brief, the 3'-untranslated region of hTERT mRNA or a series of hTERT mRNA 3'UTR mutants were amplified by PCR using the primers shown in Table S1 . The PCR products were then cloned into the pcDNA3/EGFP vector at the BamHI and EcoRI sites downstream of the EGFP coding region.
The ACVR2B and SMAD3 mRNA 3'UTRs were annealed using the primers listed in Table   S1 and cloned into the same vector mentioned above. HeLa cells were co-transfected with a reporter plasmid and either pri-miR-346, pri-miR-138 or the pcDNA3 control vector in 48-well plates. The pDsRed2-N1 vector (Clontech) expressing RFP was spiked in to normalize the transfection. After 48 hours, the cells were lysed and the fluorescence 13 intensities of EGFP and RFP were detected with a F-4500 fluorescence spectrophotometer (HITACHI).
RNA extraction and qRT-PCR
At indicated time points post transfection or post other treatments, total RNAs were extracted from cells using the TRIzol reagent (Invitrogen). Expression of mature miRNAs was determined using miRNA-specific stem-loop qRT-PCR 2,3 in an iQ5 Real-Time PCR Detection System (Bio-Rad) with the SYBR Premix Ex Taq™ Kit (TaKaRa). U6 snRNA was used for normalization. The following PCR program was used to detect mature miR-346 and miR-138:
(1) 95°C for 3 min, and (2) 
Telomerase activity detection
The activity and quantification of telomerase in the parental and transfected cervical cancer cells was detected using the TeloTAGGG Telomerase PCR ELISA PLUS kit (Roche) following the manufacturer's instructions.
Northern blot assay
Northern blot assay was performed as previously described 4 . Small RNAs were separated by electrophoresis on 20% PAGE-urea gels. The RNA was blotted and cross-linked onto nylon 14 membranes (Ambion) and hybridized with γ-32 P end-labeled (Furui Company, Beijing, China)
ASO-miR-346, 138 and U6 snRNA, respectively (sequences can be found in Table S1 ). All of the radioisotopes were imaged at −80°C.
RNA immunoprecipitation assay
RIP assay was carried out following the method described by Christoph Ufer 5 with some modifications. HeLa cells transfected with Flag-GRSF1 were trypsinized, resuspended in chilled PBS, and centrifuged at 5,000 rpm for 5 minutes at 4°C 24 hours post transfection.
The pellets were resuspended in lysis buffer [50 mM Tris-HCl, PH 7.5, 1% NP-40, 0.5% sodium deoxycholate, 1 mM EDTA, 140 mM NaCl, 1.5 mM MgCL 2 , 1 mM DTT, 100 U/ml RNasin, and 1x proteinase inhibitor cocktail (Roche)], incubated on ice for 10 minutes with occasional flicking, and then centrifuged at 16,000g at 4°C for 5 minutes. The supernatant was transferred to a new 1.5 ml tube. The samples were pre-cleaned by adding 50 µl of protein G slurry to each tube and rotating the samples at 4°C for 2 hours. After centrifugation at 5,000 g for 5 minutes at 4°C, the supernatant was transferred to a new tube. Ten µg of anti-Flag antibody was added to the supernatants; the same amount of mouse IgG was added to the non-specific control sample. After a rotation at 4°C overnight, 50 μl of protein G slurry was added to the supernatants and the samples were rotated at 4°C for 2 more hours.
Following centrifugation at 5,000 g for 5 minutes at 4°C, the supernatants were discarded and the samples were resuspended in 1 ml lysis buffer. The samples were centrifuged at 5,000 g for 5 minutes at 4°C and then the supernatants were discussed. This step was then repeated.
The pellet was then washed twice with high salt lysis buffer (the same as the lysis buffer 15 except that NaCl is at 700 mM). The RNAs in the pellets were released from the samples after proteinase K treatment for 30 minutes at 50°C, extracted with phenol: chloroform: isoamyl alcohol (25: 24: 1), and then precipitated in alcohol overnight. The RNAs were then quantified by qRT-PCR.
Dot blot hybridization assay
RNA dot hybridization was performed as described previously 6 with some modification. In 
